You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Relvar Ellipta contains two medicines, fluticasone furoate and vilanterol. Relvar Ellipta is a long-acting bronchodilator combined with an inhaled corticosteroid that is taken once daily for the treatment of asthma and COPD.

Relvar and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies